286 related articles for article (PubMed ID: 12406913)
21. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development.
Cotta CV; Zhang Z; Kim HG; Klug CA
Blood; 2003 Jun; 101(11):4342-6. PubMed ID: 12560221
[TBL] [Abstract][Full Text] [Related]
22. In utero exposure to alcohol alters cell fate decisions by hematopoietic progenitors in the bone marrow of offspring mice during neonatal development.
Wang H; Zhou H; Moscatello KM; Dixon C; Brunson LE; Chervenak R; Chervenak DC; Zhao X; Wolcott RM
Cell Immunol; 2006 Jan; 239(1):75-85. PubMed ID: 16797505
[TBL] [Abstract][Full Text] [Related]
23. Lineage commitment in lymphopoiesis.
Busslinger M; Nutt SL; Rolink AG
Curr Opin Immunol; 2000 Apr; 12(2):151-8. PubMed ID: 10712946
[TBL] [Abstract][Full Text] [Related]
24. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies.
Yu D; Dews M; Park A; Tobias JW; Thomas-Tikhonenko A
Cancer Res; 2005 Jun; 65(12):5454-61. PubMed ID: 15958595
[TBL] [Abstract][Full Text] [Related]
26. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
[TBL] [Abstract][Full Text] [Related]
27. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.
Cattoretti G; Angelin-Duclos C; Shaknovich R; Zhou H; Wang D; Alobeid B
J Pathol; 2005 May; 206(1):76-86. PubMed ID: 15772984
[TBL] [Abstract][Full Text] [Related]
28. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage.
Chiang MY; Monroe JG
Blood; 1999 Dec; 94(11):3621-32. PubMed ID: 10572073
[TBL] [Abstract][Full Text] [Related]
29. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes.
Anderson K; Rusterholz C; Månsson R; Jensen CT; Bacos K; Zandi S; Sasaki Y; Nerlov C; Sigvardsson M; Jacobsen SE
Blood; 2007 May; 109(9):3697-705. PubMed ID: 17218387
[TBL] [Abstract][Full Text] [Related]
30. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
32. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
Nutt SL; Heavey B; Rolink AG; Busslinger M
Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
[TBL] [Abstract][Full Text] [Related]
33. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.
Maier H; Colbert J; Fitzsimmons D; Clark DR; Hagman J
Mol Cell Biol; 2003 Mar; 23(6):1946-60. PubMed ID: 12612069
[TBL] [Abstract][Full Text] [Related]
34. Identification of Pax5 as a target of MTA1 in B-cell lymphomas.
Balasenthil S; Gururaj AE; Talukder AH; Bagheri-Yarmand R; Arrington T; Haas BJ; Braisted JC; Kim I; Lee NH; Kumar R
Cancer Res; 2007 Aug; 67(15):7132-8. PubMed ID: 17671180
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H
Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555
[TBL] [Abstract][Full Text] [Related]
36. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus.
Walter K; Bonifer C; Tagoh H
Blood; 2008 Sep; 112(5):1673-82. PubMed ID: 18552207
[TBL] [Abstract][Full Text] [Related]
37. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
O'Riordan M; Grosschedl R
Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
[TBL] [Abstract][Full Text] [Related]
38. Early B cell factor: Regulator of B lineage specification and commitment.
Lukin K; Fields S; Hartley J; Hagman J
Semin Immunol; 2008 Aug; 20(4):221-7. PubMed ID: 18722139
[TBL] [Abstract][Full Text] [Related]
39. Loss of Pax5 promotes plasma cell differentiation.
Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
[TBL] [Abstract][Full Text] [Related]
40. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
